tDCS Explained: The Complete Guide to Transcranial Direct Current Stimulation [2026]

You have been diagnosed with depression or chronic pain. Medication helps some people, but not everyone. Maybe the side effects are too much. Maybe you have tried two or three different prescriptions without finding the right fit. Or maybe you simply want to explore what else is out there.

Transcranial direct current stimulation (tDCS) is a non-invasive brain stimulation technique that uses a gentle electrical current to restore balance in specific brain regions. It is not new or experimental. Researchers have published over 400 clinical trials on tDCS. Hundreds of thousands of patients have been treated worldwide. And the technology has now matured to the point where you can use medical-grade tDCS safely at home, with your doctor monitoring remotely.

This guide gives you a clear, honest overview of tDCS: what it is, how it works, what the evidence shows, and what treatment actually looks like day to day. You can read the full overview here and follow optional links

In 30 seconds: tDCS sends a very low electrical current (1-2 milliamps — about a thousand times weaker than a light bulb) through two soft electrodes placed on your head. This gently adjusts activity in the targeted brain area. It does not require anesthesia. You stay fully awake and can go about your day afterward. You can do it at home. Clinical trials show remission rates of up to 57.5% for depression, with mostly mild and temporary side effects like brief tingling on the skin. For CE-marked devices such as Sooma tDCS™, approved indications are major depressive disorder and chronic pain due to fibromyalgia, knee osteoarthritis, or neuropathic pain in MS, SCI, or phantom limb pain.

---

What is tDCS (transcranial direct current stimulation)?

tDCS stands for transcranial direct current stimulation. Let's break that down:

• Transcranial means "through the skull."
• Direct current means a steady, one-way flow of electricity.
• Stimulation means gently influencing brain activity.

In practice, two soft electrodes are placed on your head using a comfortable headcap. A small, portable device sends a weak electrical current between them. This current passes through the cranium to reach the brain. The current is so low — about the same as what flows through a small hearing aid battery — that you might only feel a mild tingling on your skin, and nothing more. Many people describe it as a slight warmth that fades after a few minutes.

Who is tDCS for?

Sooma tDCS™ is indicated, as a stand-alone or adjunctive treatment, for the treatment of:

1. Major depressive disorder — see tDCS for Depression in our glossary, or the full guide
2. Chronic pain due to:

• Fibromyalgia
• Knee osteoarthritis
• Neuropathic pain in multiple sclerosis (MS), spinal cord injury (SCI), or phantom limb pain

How tDCS differs from ECT, TMS, and medication

tDCS is often confused with other brain stimulation treatments. Here is what makes it different:

• Unlike ECT (electroconvulsive therapy): tDCS does not cause seizures. There is no anesthesia, no memory loss, and no recovery time. You stay fully awake and alert.
• Unlike TMS (transcranial magnetic stimulation): tDCS does not require expensive clinic equipment. The device is portable and designed for home use.
• Unlike medication: tDCS works directly on the brain region involved, rather than affecting your whole body. There are no systemic side effects like weight gain or sexual dysfunction, and no development of tolerance or withdrawal.

Think of it this way: if your brain were a garden, tDCS would be a gentle rain that helps the right areas grow. It does not flood the whole garden the way medication can, and it is not a storm like ECT — highly effective, but intense.

Another way to think about it: medication travels through your entire bloodstream and affects many systems in your body, which is why it can cause side effects like weight gain or sexual dysfunction. tDCS targets specific brain areas. The rest of your body is not involved, which is why systemic side effects simply do not occur.

The Sooma tDCS system is classified as a CE Class IIa medical device in Europe — the same regulatory category as insulin pumps and hearing aids. Not all tDCS devices meet this standard. Many consumer devices sold online are not classified as medical devices and are not held to the same rigorous safety and performance requirements. Choosing a certified medical-grade device matters.

---

How tDCS works: gentle current, two electrodes, real change

To understand tDCS, you need to know that it works in two directions at once. Two soft electrodes are placed on your head:

• The positive electrode gently increases activity in the brain area beneath it, making neurons more ready to fire.
• The negative electrode does the opposite — it calms the area beneath it, making neurons less likely to fire.

This two-way action is what allows tDCS to restore balance.

For depression: The left side of the dorsolateral prefrontal cortex (the area behind your left forehead involved in mood regulation) tends to be underactive. At the same time, the right side — linked to negative emotions and withdrawal — is often overactive. tDCS addresses both: the positive electrode boosts the underactive left side, while the negative electrode calms the overactive right side. tDCS does not force neurons to activate the way ECT does. It gently nudges the natural balance between the two sides back towards normal.

For chronic pain: The mechanism is different. Chronic pain often involves changes in how the brain processes pain signals — the brain and nervous system become overly sensitive over time. tDCS places the positive electrode over the motor cortex. This activates your brain's built-in pain-dampening system — called descending inhibitory pathways. Think of it as turning on a brake: stimulating the motor cortex sends signals down the spinal cord that turn down the volume on pain signals coming up from the body.

Over repeated tDCS sessions, these adjustments accumulate. The brain begins to form new patterns of activity. Researchers call this neuroplasticity — the brain's ability to reorganize and adjust its connections. tDCS supports this natural process rather than overriding it.

What does a tDCS session feel like?

Most people feel a mild tingling or warmth on the skin under the electrodes during the first few minutes. This typically fades as the session continues. The sensation is gentle enough that you can read, watch TV, work on your computer, or simply relax during treatment. You remain fully alert and aware throughout. Sessions last 20-30 minutes (depending on treatment condition), and there is no recovery time afterward — you can carry on with your day immediately.

Why tDCS results build over time

Like learning a new skill, tDCS builds its effects over days and weeks. Each session reinforces new patterns in your brain. One session will not transform you, but a consistent course of treatment can make a meaningful difference.

A typical treatment course for depression involves 30-minute sessions, 5 times per week, typically over 3 weeks, followed by maintenance sessions to sustain the benefit.

---

Does tDCS work? what the research shows

When you are considering any treatment, the evidence matters. You want to know: Does this actually work? How well? And for how long?

tDCS is not an experimental treatment. It is backed by A-level evidence in international neuromodulation guidelines (Fregni et al. 2021) — the highest level of recommendation. This puts it in the same evidence category as established treatments like TMS.

Here is what the key studies show:

57.5% remission rate: the Nature Medicine trial (2025)

The most recent and rigorous study was published in Nature Medicine (Woodham et al. 2025). This randomized controlled trial enrolled 174 patients with depression who used tDCS at home.

• 57.5% achieved remission (their depression went away)
• Treatment was self-administered at home with remote medical supervision
• Depression improved across clinician ratings and self-reports — compared with the placebo device, active tDCS produced larger score drops on clinician-administered scales (HDRS, MADRS) and on self-report (MADRS-S).

This is a significant result. For context, typical remission rates with antidepressant medication range from 30-40%.

Real-world results: 55-68% response rates

Clinical trials are controlled environments. What happens in the real world?

A large real-world study by Lookene et al. (2022) followed 410 patients using tDCS in everyday clinical settings:

• 55% responded to treatment (a meaningful improvement in symptoms)
• 68% responded when tDCS was used on its own (without medication)
• These are real patients, not carefully selected trial participants

Do tDCS benefits last? long-term data

One of the biggest questions with any treatment: do the benefits last?

• 76% maintained their response at 6 months with maintenance sessions (Woodham et al. follow-up data)
• In a maintenance study after an acute response, 73.5% remained relapse-free over 24 weeks overall with twice-weekly sessions (Aparicio et al., 2019)
• This compares favorably to antidepressant medications, where relapse rates are often higher

tDCS vs antidepressant medication: head-to-head trial

The SELECT-TDCS trial (Brunoni et al. 2013, 120 patients) compared tDCS directly with sertraline, a commonly prescribed antidepressant medication. tDCS showed comparable effectiveness, but with a very different side effect profile: no weight gain, no sexual dysfunction.

33,000+ sessions with no serious side effects

Across 33,000+ documented sessions, there have been no serious adverse events (Bikson et al. 2016). This is one of the most robust safety records among brain stimulation treatments.

---

What does tDCS treat?

tDCS for depression

Depression is the condition with the strongest evidence for tDCS. The studies cited above focus on major depressive disorder, and tDCS holds A-level evidence for this indication — the highest level of clinical recommendation.

tDCS is particularly worth considering if:

• Antidepressant medication has not worked well enough for you
• You have tried multiple medications without adequate relief
• Side effects from medication are affecting your quality of life
• You prefer a non-pharmaceutical approach (antidepressant alternatives)
• You want a treatment you can do at home without regular clinic visits

tDCS can be used on its own or alongside existing medication. In fact, many patients use it as an add-on to their current treatment plan, and the SELECT-TDCS trial found that combining tDCS with sertraline produced better results than either treatment alone.

tDCS for chronic pain

tDCS also shows meaningful results for chronic pain conditions, with Level B evidence in clinical guidelines (Fregni et al. 2021). A meta-analysis focused on fibromyalgia patients (Cheng et al. 2023, 414 patients) supports its use for pain management.

For chronic pain, the electrode is placed over a different brain area — the motor cortex rather than the prefrontal cortex. The underlying mechanism is similar: gently restoring balance to brain activity in the region that processes and regulates pain signals.

The evidence for pain is not yet as strong as for depression, but it is growing. If you live with chronic pain and current treatments are not giving you enough relief, tDCS is worth discussing with your doctor.

---

How to use tDCS at home

One of the biggest advantages of tDCS is that you can use it at home. But there is an important distinction: a medical-grade home device is not the same as a DIY kit bought online.

medical-grade tDCS vs DIY devices: why it matters

If you search online for "tDCS device," you will find cheap consumer gadgets alongside medical-grade systems. These are not the same thing.

DIY tDCS devices sold on general electronics websites have no medical oversight. The electrode placement, current strength, and treatment duration are based on guesswork, not clinical evidence. Placing electrodes in the wrong position or using the wrong current can be ineffective at best and potentially harmful. Brain stimulation is not something to improvise.

Medical-grade tDCS, such as Sooma tDCS™, is a CE Class IIa-certified medical device. It uses the same validated treatment parameters from the clinical trials cited above. You can purchase it directly for home delivery, and the Sooma App guides you through each session. The results in the studies on this page were achieved with medical-grade devices — not consumer gadgets.

What's included: the Sooma tDCS system

Sooma tDCS includes four components that work together:

1. Sooma DUO device — a compact, portable stimulator that delivers precise, controlled current
2. ComfoCap — a headcap that guides correct electrode positioning every time (electrodes connect through the cap to the leads — no guesswork about placement)
3. Sooma App — guides you through each session step by step, records your treatment data, and tracks your progress over time
4. Sooma Portal (available with professional clinical packages) — a secure dashboard where your clinician can monitor your progress remotely and adjust your treatment course

What a typical tDCS session looks like

1. Place the single-use conductive pads (Conductive Pads) into the electrode cups
2. Put on the ComfoCap (takes about a minute)
3. Open the Sooma App and start your session
4. Feel a brief tingling as the session begins
5. Sit comfortably for 30 minutes — read, watch something, or just relax
6. The device switches off automatically when done

You do this 5 times per week during the active treatment phase (typically 3 weeks). After that, maintenance sessions — typically 3 times per week — help sustain the benefits. Your treatment includes 6 months of access in total.

Ongoing support and progress tracking

The Sooma App is your built-in treatment companion. It tracks every session, records your treatment data, and lets you monitor your progress over time — so you can see how your treatment is working and stay motivated throughout your course. Clinically validated outcome questionnaires are built into the app, giving you a clear picture of your progress. If your treatment is managed through a professional clinical package, your clinician can also monitor your data remotely through the Sooma Portal.

How much does tDCS cost?

Sooma tDCS™ Therapy costs 599€ as a one-time payment for 6 months of treatment, or 129€ per month for 6 months. You keep the device and can use it for maintenance sessions long term. Compare this to clinic-based treatments like TMS, which often cost 5,000€ to 10,000€ or more

---

tDCS side effects and safety

Every treatment has side effects. With tDCS, they tend to be mild and temporary.

Common tDCS side effects

• Mild tingling or itching under the electrodes during the session — this is the most commonly reported sensation, and most people say it fades within the first few minutes
• Temporary skin redness at the electrode site, which typically fades within an hour after the session ends
• Mild headache after the first few sessions, which usually resolves as you continue with treatment

These side effects are mild enough that they rarely cause people to stop treatment. In clinical studies tracking over 33,000 sessions, no serious adverse events have been reported. This is a safety record that very few treatments — pharmaceutical or otherwise — can match.

What tDCS does NOT cause

Unlike many medications used for depression, tDCS does not cause:

• Weight gain
• Sexual dysfunction
• Drowsiness or brain fog
• Withdrawal symptoms if you stop

This is because tDCS targets a specific brain region rather than affecting your whole body through the bloodstream. No chemicals are added to your system. When you stop using tDCS, there is no withdrawal period and no tapering required. You simply stop.

Who should NOT use tDCS

tDCS is safe for most adults, but there are two contraindications:

• Devices or metal objects on or inside the skull (such as cochlear implants or metal plates from surgery). The metal can interfere with the current flow.
• Acute eczema or broken skin at the electrode site. The electrodes need healthy skin to work properly and comfortably.

If you are unsure whether tDCS is right for you, a healthcare provider can help you assess your suitability.

---

tDCS vs TMS, medication, ECT, and Ketamine

If you are weighing treatment options, the practical differences matter as much as the clinical evidence. How does tDCS compare to other approaches in terms of where you receive treatment, what side effects to expect, and what it costs? Here is a practical overview:

	tDCS	TMS	Oral antidepressant medication	ECT	Ketamine
Where	Home	Clinic	Home	Hospital	Clinic
Session time	30 min	20-40 min	N/A (daily pill)	Under anesthesia	40-60 min
Treatment course	3 weeks, 5x/week + maintenance	4-6 weeks, 5x/week	Ongoing	6-12 sessions	6 infusions over 2-3 weeks
Systemic side effects	None	Headache, scalp pain	Weight gain, sexual dysfunction, nausea, withdrawal	Anesthesia-related nausea, confusion, sedation	Dissociation, nausea, blood pressure changes
Requires clinic visits	No	Yes, every session	No (pharmacy)	Yes, every session	Yes, every session
Approximate cost	599€	EUR 5,000-10,000€+	EUR 20-100€/month	Varies widely	EUR 400-800€/infusion
Evidence level (depression)	A-level	A-level	A-level	A-level	Emerging

How tDCS compares: key takeaways

• tDCS and TMS are both non-invasive brain stimulation with A-level evidence. The clearest difference is practical: tDCS can be done at home, while TMS is performed in-clinic using a large device and requires attending every session in person over several weeks. TMS is becoming more widely offered in specialist clinics today, and clinicians often favor it
• tDCS and medication show comparable effectiveness in head-to-head trials (SELECT-TDCS), but the side effect profiles are very different. tDCS has no systemic side effects, while antidepressant medications commonly cause weight gain, sexual dysfunction, and withdrawal symptoms. Many patients use both together for the best results.
• ECT remains the most effective treatment for severe, treatment-resistant depression. However, it requires hospital visits, general anesthesia, and carries a risk of memory loss. It is typically reserved for the most severe cases.
• Ketamine is showing promise but the evidence is still emerging. It requires clinic supervision for each infusion and can cause dissociation, nausea, and blood pressure changes during and after treatment.

---

Next steps

If you have read this far, you are clearly serious about exploring your options. Here is how to take the next step:

For patients and caregivers:

• Explore Sooma tDCS — see how the full system works, what a treatment course looks like, and what to expect

For healthcare professionals:

• Sooma for Professionals — access clinical evidence summaries, clinical information, and learn about the Sooma Portal for remote patient monitoring